Japanese company reaches $2bn deal to develop Alzheimer’s vaccine
Japan’s Takeda Pharmaceuticals has reached a deal worth up to $2.2bn to develop an Alzheimer’s vaccine made by Swiss start-up AC Immune, as drug companies race to invest in potentially lucrative new treatments for the disease.
Japanese company reaches $2bn deal to develop Alzheimer’s vaccine
2T2C: Talent, Technology, Capital, Cognition

Japanese company reaches $2bn deal to develop Alzheimer’s vaccine

Photo: AFP/Nurphoto/Jakub Porzycki 
Eurasia 21/05/2024 12:25

Japan’s Takeda Pharmaceuticals has reached a deal worth up to $2.2bn to develop an Alzheimer’s vaccine made by Swiss start-up AC Immune, as drug companies race to invest in potentially lucrative new treatments for the disease.

The vaccine is one of a wave of new drugs heading for the market, including lecanemab, developed by Japanese company Eisai, which received US regulatory approval last year, Financial Times reported.

In the Takeda deal, AC Immune will receive an upfront payment of $100mn, rising to $2.1bn if milestones are reached, as well as more than 10 per cent in royalties from any worldwide sales.

The Japanese group could advance the product to late-stage, phase 3 trials, AC Immune said, but regulatory approval could take several years.

Early trials had identified no safety concerns, said Andrea Pfeifer, chief executive of the biotech. But AC Immune would not have efficacy data for the drug until it completed a mid-stage trial within the next 12 months.
#Japan
See Also
Serving innovation
Serving innovation

It is with great enthusiasm that I extend a warm welcome to our Hungarian colleagues and partners to explore the dynamic and diverse opportunities presented by the Astana International Financial Centre (AIFC).

Trump announces $500 billion Japan-UAE-US joint venture Stargate
Trump announces $500 billion Japan-UAE-US joint venture Stargate

U.S. President Trump announced on Tuesday a substantial investment in artificial intelligence infrastructure within the United States. The initiative will be funded through an American-Japanese-UAE joint venture known as the Stargate Project.
Second fact-finding mission to China: Exploring university-industry cooperation innovations
Second fact-finding mission to China: Exploring university-industry cooperation innovations

In October 2024, a delegation, from the Learning Institute of the Mathias Corvinus College (MCC) in Budapest embarked on a second fact-finding mission to China. This mission, part of the "Learning from Asia" (LfA) project, aimed to build on the insights gained during a similar tour in May 2023 and the "Learning from Asia in Education" international conference held in Budapest in October 2023.

We use cookies on our website. If you consent to their use, we use them to measure and analyze the use of the website.
Information and Settings

Accept